A detailed history of First Pacific Financial transactions in Abb Vie Inc. stock. As of the latest transaction made, First Pacific Financial holds 200 shares of ABBV stock, worth $35,602. This represents 0.01% of its overall portfolio holdings.

Number of Shares
200
Previous 217 7.83%
Holding current value
$35,602
Previous $37,000 5.41%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $2,785 - $3,388
-17 Reduced 7.83%
200 $39,000
Q2 2024

Jul 19, 2024

SELL
$154.79 - $180.76 $4,179 - $4,880
-27 Reduced 11.07%
217 $37,000
Q1 2024

Apr 24, 2024

BUY
$159.82 - $182.1 $7,032 - $8,012
44 Added 22.0%
244 $44,000
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $26,502 - $32,980
200 New
200 $26,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track First Pacific Financial Portfolio

Follow First Pacific Financial and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Pacific Financial, based on Form 13F filings with the SEC.

News

Stay updated on First Pacific Financial with notifications on news.